Search

Heather Henry explains what nurses need to cover when conducting an asthma review [ABSTRACT FROM AUTHOR]

The article offers information on the multifunctional role of lungs beyond basic respiration, highlighting their immune filtering capabilities, regulation of blood pressure through hormone processing, and their intricate structure for gas exchange. Topics include the lungs' role as a major immunological filter against pollution and pathogens, their extensive network of airways and alveoli for efficient gas exchange, and their critical function in maintaining blood pressure.

Heather Henry explains how nurses can help patients to prevent asthma from disturbing sleep [ABSTRACT FROM AUTHOR]

The article highlights the significance for dental providers in understanding and implementing an effective medical emergency management protocol to ensure the safety and well-being of patients and help promote a secure and trusting environment. Cited are the common risk factors for medical emergencies in dental settings, the impact of severity assessment of a medical emergency to patient outcomes, and key emergency equipment and medications that every dental office should have.

Beverley Bostock looks at how the changing weather may impact respiratory conditions [ABSTRACT FROM AUTHOR]

Many patients have contemporaneous features of asthma and COPD, and it is estimated that a significant proportion of these patients have asthma-COPD overlap, write Emma Ray and Carol Kelly [ABSTRACT FROM AUTHOR]

Presents a profile of Genentech Inc., the world's oldest biotechnology company, and its CEO Arthur D. Levinson. Three new drugs expected to be launched by Genentech within a year, including colon cancer drug Avastin, asthma treatment Xolair and psoriasis drug Raptiva; Genentech's position as the second-largest biotechnology company after Amgen Inc.; Speculation that Genentech could become much larger if the new drugs succeed; Company's share price; Risks associated with the launch of new drugs; Levinson's career as a scientist and his rise through the ranks of Genentech; His attempts to establish the company as a pharmaceutical house; His management style; His reputation for unconventionality, creativity and financial savvy; Genentech's errors under Levinson; Genentech's refusal to market its prescription drugs to consumers; Potential criticisms by insurers and politicians about the high cost of the company's new drugs.

The article offers tips for managing asthma, a common inflammatory disease of the airways that affects about 11 percent of the Australian population. Topics covered include the pathophysiology of asthma, the factors that may increase the risk of developing the disease, and the ways to significantly decrease asthma morbidity and mortality.

The article reports on a New Drug Application (NDA) accepted by the U.S. Food and Drug Administration (FDA) for PTO27 pressurized metered-dose inhaler developed by AstraZeneca and Avillion as a potential rescue treatment for asthma. Topics include the components of the drug, results from different clinical trials of PTO27 such as MANDALA, DENALI and TYREE wherein NDA submission was based, and statistics on asthma exacerbations experienced by asthma patients worldwide.

The article offers information on the Asthma as the chronic illness of childhood and several suggestions to check the symptoms including wheezing at the end of a cough or when the child exhales; feeling of tightness in their chest; and frequent coughing.

Focuses on research into how treatment to prevent organ rejection in transplant surgery is being used to treat asthma. Why researchers are optimistic about this type of treatment; Side effects of current substances used to treat asthma; Explanation of extrinsic and intrinsic asthma; Trials with cyclosporin A. INSET: Who suffers from asthma?.

Focuses on research on psychosomatic medicine. Application of these medicine in the treatment of asthma, peptic ulcer, arthritis and warts; Effect of intense emotions like love, hate, anger and fear on body metabolism; Evaluation of the patient's unconscious emotional conflicts by practitioners of psychosomatic medicine; Theories on psychoanalysis expounded by Austrian physician Sigmund Freud; Discussion of organic and functional diseases; Promotion of research on psychosomatic medicine by physician H. Flanders Dunbar, the Rockfeller Foundation and Chicago Institute of Psychoanalysis.

Purpose: Current asthma guidelines combine treatment, follow-up, and reevaluation to manage asthma control, reduce impairment, and decrease risk of morbidity in patients. Clinical use of biomarkers, such as fractional exhaled nitric oxide (FeNO), along with standard management can provide clinicians with improved ability to recognize airway inflammation, optimize drug therapy, and potentially increase asthma control. Our objective is to examine the impact of FeNO monitoring on the cost effectiveness of asthma management compared with management without FeNO. Sensitivity analyses further examine the impact of FeNO monitoring on patients with varying levels of severity and exacerbations.Design and Methods: A decision-tree analysis of estimated outcomes and costs associated with annual management of asthma was utilized to simulate asthma management and treatment cost scenarios, comparing estimated 12-month costs and outcomes using the following treatment alternatives: (1) current standard of care (SOC) or (2) FeNO utilized in conjunction with the current SOC. Costs were estimated from the perspective of the health care payer; cost effectiveness was estimated as cost per quality-adjusted life year (QALY).Results: FeNO in conjunction with SOC guidelines has decreased expected per-patient annual expenditure ($2,228) and increased expected per-patient annual QALYs (0.844) compared with SOC alone ($2,637 and 0.767). FeNO monitoring with SOC resulted in decreased annual costs and increased annual QALYs compared with SOC alone, and this difference was consistent through all one-way sensitivity analyses.Conclusion: Our analysis revealed that FeNO monitoring to guide asthma management is cost effective and could result in increased QALYs and decreased health care costs associated with asthma management. [ABSTRACT FROM AUTHOR]

The article presents tips for parents on how to keep their children safe from allergies during the spring season. Topics include allergic Rhinitis, spring catarrhh, and asthma being some of the allergies faced by kids, tips on how to keep allergens away from the child or their surroundings, and the various treatment options available.

The article presents a guideline aimed at improving the accuracy of chronic asthma diagnosis as well as helping people to control it and reduce the risk of attacks. Topics include the initial clinical assessment of people with suspected asthma, pharmacological treatment pathway for adults, and decreasing maintenance therapy. The provision of medical personnel of asthma self-management programme to adults, young people and children aged five and over diagnosed with asthma is also explored.

This article reports on drugs being developed to provide relief for asthma patients as of May 2005. Researchers at the University of California at San Francisco and Lawrence Berkeley national Laboratory announced in April that they have identified a stretch of DNA that controls three genes that play major roles in asthma. Genentech Inc.'s anti-IgE drug, taken as a shot every two to four weeks, blocks immunoglobulin from attaching to cells. Immunex Corp. hopes to reach more sufferers by moving further up the cascade with Nuvance, currently in midstage trials. Nuvance soaks up a specific interleukin, IL-4, that is a key actor in the production of mucus and inflammation.

The article explains the need for dental hygienists to understand asthma as a disease and its treatment in order to provide safe and proper care for their patients. It explores the etiology, pathophysiology and pharmacologic management of asthma. It recognizes the possibility of patients getting exposed to the triggers of an asthma attack during a dental hygiene appointment which may include aerosols, water and pathogens from the use of high-speed equipment and stress.

Explores approaches to treating asthma. Limitations of anti-inflammatory therapy; Control of immunoglobulin E; Regulation of cellular inflammation; Locating the asthma gene.

The article presents information on pangolins that are increasingly becoming victims of illegal wildlife crime due to their meat and scales. It mentions that pangolin scales are used in traditional medicine and folk remedies to treat asthma, rheumatism and arthritis. It also mentions that several pangolin species are protected under national and international laws.

The article points out that asthma should not stop children from living healthy and active lives if the condition is properly managed with medicine. Topics include how to know if a child has asthma, treatment of a child's asthma and the considerations in growing up with asthma, such as daily medication, getting a flu shot and keeping away from smoke.

The article discusses the reasons to target asthma as a population health initiative with the use of SmartAirLA, a program that focused on underserved children with asthma in Los Angeles County, California. These reasons the significant challenges presented by asthma to healthcare, the simple deployment of the technology behind the program, and the focus of the initiative on underserved children that live in the polluted areas.

Mark Greener details the latest clinical studies relevant to primary care nurses [ABSTRACT FROM AUTHOR]

An interview with general practitioner (GP) Mark Levy is presented. Levy discusses a guideline for asthma management released by the British National Institute for Health and Care Excellence (NICE). He also talks about the access to fractional expired nitric oxide (FeNO) measurement or airway hyperactivity testing and the common differential diagnoses for asthma.

The article discusses the development of a new drug that can relax specific muscles which can be useful in treating asthma.

The article reports on the agreement signed by clinical artificial intelligence (AI) firm Sensyne Health with Oxford University for the conduct of a multi-omics drug discovery research project to treat asthma. Sensyne will use machine learning and proprietary analytical tools in the research. Also cited is the comment of the university's Doctor Timothy Hinks on the research project.

The author discusses the need of collaboration between doctors and patients to control patients' asthma and allergy. Topics discussed include collaborative practices involving healthcare teams including pulmonologist, respiratory therapist, and nurse practitioner, benefits of team-based healthcare works for patients with chronic conditions such as asthma, and role of school nurses in collecting children's health information and prioritizing emergency care plans for children.

The article presents information related to an increase of adult-onset asthma that begins once someone is beyond their teens. It is mentioned that shortness of breath, coughing and wheezing are some of the symptoms of asthma. It is stated that lung function in women is affected by hormonal changes which makes women more vulnerable to develop asthma than men.

The article presents tips on how to manage a child with asthma. Topics cited include how to determine if a child has asthma, how to properly use meteredose inhalers (MDIs) or puffers to control a child's wheezing, shortness of breath and coughing, and how doctors classify asthma and prescribe the correct medications for treating asthma. It discusses tips on proper asthma care and how to use an inhaler with a spacer and mask.

The article features the semifinalists of the 2017 Healthcare Informatics Innovator Awards. These include the strategic plan for population health management of Children's Hospital of Orange County in California, the electronic health record technologies used in obstetrics and gynecology (OB) departments of St. Lakeland Health in Michigan, and the business intelligence reporting tool (BIRT) of the Community Health Centers in Ontario.

The article offers suggestions for maintaining g good health by utilizing the morning time. Topics discussed include risk of heart disease with elevated cortisol levels, importance of early-morning workouts, use of antidepressants by most of the Australians, vitamin D supplement for treatment of asthma, and boost in well-being by interacting with friends on online social networking Facebook.

The article discusses several medical conditions including diabetes, obesity, and asthma. Topics include symptoms of diabetes and its presence in children, obesity in children and ways to manage the health issue, and cause of asthma and different practices to manage and control the particular condition.

The article offers information on several medications for respiratory disorders. The Arcapta Neohaler, a long-acting beta-2 agonist (LABA), is developed for the treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD). Asthmatic patients can be treated with Asmanex Twisthaler from pharmaceutical company Merck & Co. Inc. The Alavert D-12 Hour antiallergic drug is indicated for the treatment of seasonal allergic rhinitis in patients with nasal congestion.

The article discusses the significance of yoga to the health of children especially in their fun activity and treatment. Studies associating yoga with the improvement of children having asthma, autism and irritable bowel syndrome is noted. It is pointed out that yoga helps children get relaxed and their anxiety managed easily. INSET: yoga tricks for kids.

The article offers information on drugs used in treatment of respiratory disorders. It states that anoro ellipta from GlaxoSmithKline is used in treatment of chronic obstructive pulmonary disease (COPD) and has side effects like sinusitis and neck pain. It mentions that Asmanex Twisthaler from Merck should not be taken by pregnant women. It highlights that one can take Flovent HFA from GiaxoSmitbKline for treatment of asthma.

The article presents the Ready Reference Guide for pediatricians for asthma management in children, from National Asthma Education and Prevention Program at National Heart, Lung, and Blood Institute (NHLBI). It also presents tables on NHLBI guidelines on assessment and monitoring of asthma control including classification of asthma severity and treatment initiation by age, asthma control assessment and therapy adjustment by age, and 2007 NHLBI stepwise treatment recommendations by age.

The article discusses the health benefits of owning pets. It states that people who own pets such as dogs, tends to exercise more due to the playful personality of their dog. It notes that pets help lower blood pressure and reduce anxiety. It mentions that children who are exposed to furry animals have lesser risk of allergies and asthma.

The article provides prescription data on several pharmaceutical drugs used for the treatment of respiratory disorders including asthma, cough, and rhinitis. It states that Accolate is a leukotriene receptor antagonist from AstraZeneca that can be used for the treatment of prophylaxis and asthma. It adds the applicability of GlaxoSmithKline's Veramyst to adults and children suffering from perennial and seasonal allergic rhinitis.

The article suggests tips for helping children improve adherence to asthma treatment. Topics covered include clinician-related and patient related barriers to adherence to recommended treatment, the need to ensure close and repeated follow-up to help build trust and partnership and how to express empathy using active listening techniques tailored to the patient's needs.

The author discusses the ancient Chinese medical practice of tuina which effects physical, emotional, and mental relaxation in people. Topics covered include its combination of channel palpation, acupressure and body manipulation, its benefits for muscular issues arising from qi and blood stagnation, and its physiological processes. Also noted are practitioners' varied delivery of tuina with patients.

The article focuses on the biggest selling album and undiagnosed illness of English musician Tricky. It states that the surprising success of his debut album "Maxinquaye" in 1995 has been confusing and impenetrable to him. It says that Tricky has suffered from the personality-altering effects of candidiasis, a fungal infection caused by excessive use of asthma medication.

The article offers brief information several drugs for the treatment of respiratory disorders including Arcapta Neohaler for bronchoconstriction from Novartis AG, Advair HFA 45/21 for asthma from GlaxoSmithKline, and Claritin-D 24 Hour for seasonal allergic rhinits from Merck & Co. Inc

The article reports that climate change is leading to more pollen and asthma problems. The ground-level ozone reaches unhealthy levels in cities on hot days that makes the air more difficult to breathe. Increased pollen is also a consequence of global warming contributing to allergy and asthma problems.

The article discusses medicine and treatments for respiratory disorders particularly asthma. It says that Accuneb from Dey is used as treatment for bronchospasm but not recommended for adults. It states that Advair Diskus 100-50 is used for maintenance treatment of asthma in patients not adequately controlled with asthma-controller medications. It adds that Asmanex Twisthaler is used as prophylactic therapy for asthma.